BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 2 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2023. The put-call ratio across all filers is - and the average weighting 6.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,118,000 | -4.9% | 62,245 | +16.7% | 3.37% | +296.8% |
| Q3 2019 | $2,226,000 | -22.1% | 53,345 | -18.2% | 0.85% | -9.3% |
| Q2 2019 | $2,857,000 | -27.3% | 65,249 | -14.6% | 0.94% | -8.4% |
| Q1 2019 | $3,931,000 | +0.6% | 76,379 | -27.7% | 1.02% | -20.3% |
| Q4 2018 | $3,909,000 | -1.5% | 105,706 | 0.0% | 1.28% | +46.6% |
| Q3 2018 | $3,969,000 | -5.0% | 105,706 | 0.0% | 0.88% | -2.7% |
| Q2 2018 | $4,178,000 | +53.4% | 105,706 | 0.0% | 0.90% | +51.8% |
| Q1 2018 | $2,723,000 | -4.5% | 105,706 | 0.0% | 0.59% | -25.9% |
| Q4 2017 | $2,852,000 | +280.3% | 105,706 | +252.4% | 0.80% | +226.5% |
| Q2 2017 | $750,000 | – | 30,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |